Bycus Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.33 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -71.66%
- Profit Growth -127.36%
- Ebitda -0.67%
- Net Worth 245.63%
- Total Assets 223.60%
About Bycus Therapeutics
Bycus Therapeutics Private Limited (BTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 April 2020 (Five years and one month 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.33 M, as per Ministry of Corporate Affairs (MCA) records.
Lavanya Sunkara, Nishanth Pasaru, and Nageswara Pulipati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73200TG2020PTC140175
- Company No.
140175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Bycus Therapeutics Private Limited
Explore comprehensive data for Bycus Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Bycus Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lavanya Sunkara  | Director | 23-Apr-2020 | Current |
| Nishanth Pasaru | Director | 23-Apr-2020 | Current |
| Nageswara Pulipati | Director | 23-Apr-2020 | Current |
Financial Performance of Bycus Therapeutics.
Bycus Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.66% decrease. The company also saw a substantial fall in profitability, with a 127.36% decrease in profit. The company's net worth Soared by an impressive increase of 245.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bycus Therapeutics?
In 2023, Bycus Therapeutics had a public holding of 14.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Agri Bio Innovations Private LimitedLavanya Sunkara and Nishanth Pasaru are mutual person
- Bycus Bio Sciences Llp
Lavanya Sunkara, Nishanth Pasaru and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bycus Therapeutics?
Bycus Therapeutics has a workforce of 46 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bycus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bycus Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bycus Therapeutics
Recent activity within the organization
- Annual General Meeting
Bycus Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Bycus Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Lavanya Sunkara was appointed as a Director was appointed as a Director on 23 Apr 2020 & has been associated with this company since 5 years 1 month .
- Director Appointment
Nishanth Pasaru was appointed as a Director was appointed as a Director on 23 Apr 2020 & has been associated with this company since 5 years 1 month .
- Director Appointment
Nageswara Rao Pulipati was appointed as a Director was appointed as a Director on 23 Apr 2020 & has been associated with this company since 5 years 1 month .
- Company Incorporation
Bycus Therapeutics Private Limited was registered on 23 Apr 2020 with Roc Hyderabad & aged 5 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Bycus Therapeutics Private Limited?
Bycus Therapeutics Private Limited was incorporated on 23 Apr 2020.
What is authorized share capital and paid-up capital of Bycus Therapeutics Private Limited?
The authorized share capital of Bycus Therapeutics Private Limited is ₹ 4.00 M and paid-up capital is ₹ 2.33 M.
Who are the current board members & directors of Bycus Therapeutics Private Limited?
Currently 3 directors are associated with Bycus Therapeutics Private Limited.
- Lavanya Sunkara
- Nishanth Pasaru
- Nageswara Rao Pulipati
What is the registered address of Bycus Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bycus Therapeutics Private Limited is Suite No.13 Ouh Bio-Nest School Of Lifesciences, C/O University Hyderabad India, Gachibowli, Telangana, 500046.
What is the corporate identification number (CIN) and company number of Bycus Therapeutics Private Limited?
The corporate identification number (CIN) of Bycus Therapeutics Private Limited is U73200TG2020PTC140175 and the company number is 140175 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bycus Therapeutics Private Limited?
The Official website of Bycus Therapeutics Private Limited is https://www.bycusbio.com
What has been the recent revenue trend for Bycus Therapeutics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Bycus Therapeutics Private Limited has fallen by -71.66%.
How many employees does Bycus Therapeutics Private Limited currently have?
As Per 2023 financial reports, 46 employees are currently employed by Bycus Therapeutics Private Limited.
What change has been observed in the net worth of Bycus Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Bycus Therapeutics Private Limited has experienced an upsurge of 245.63%.
When was the last Balance Sheet of Bycus Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Bycus Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records